We came across a bullish thesis on Ambev S.A. on CompoundingLab’s Substack. In this article, we will summarize the bulls’ thesis on ABEV. Ambev S.A.'s share was trading at $2.57 as of December 1st. ABEV’s trailing and forward P/E were 13.45 and 13.26 respectively according to Yahoo Finance.
[caption id="attachment_605087" align="aligncenter" width="750"]Ambev appears undervalued, trading at roughly a 23% discount to fair value, implying potential 9% annual alpha if the gap closes within three years. The valuation assumes a 10-year and...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.